CSTL

CSTL

USD

Castle Biosciences Inc. Common Stock

$33.815+0.705 (2.129%)

Prix en Temps Réel

Healthcare
Diagnostics & Research
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$33.110

Haut

$34.340

Bas

$32.510

Volume

0.67M

Fondamentaux de l'Entreprise

Capitalisation Boursière

987.0M

Industrie

Diagnostics & Research

Pays

United States

Statistiques de Trading

Volume Moyen

0.44M

Bourse

NGM

Devise

USD

Intervalle sur 52 Semaines

Bas $14.59Actuel $33.815Haut $34.64

Actualités Connexes

Analyst Upgrades

BTIG Maintains Buy on Castle Biosciences, Raises Price Target to $38

BTIG analyst Mark Massaro maintains Castle Biosciences with a Buy and raises the price target from $32 to $38.

Voir plus
BTIG Maintains Buy on Castle Biosciences, Raises Price Target to $38
Analyst Upgrades

Baird Maintains Outperform on Castle Biosciences, Raises Price Target to $41

Baird analyst Catherine Ramsey maintains Castle Biosciences with a Outperform and raises the price target from $39 to $41.

Voir plus
Baird Maintains Outperform on Castle Biosciences, Raises Price Target to $41
GlobeNewswire

Castle Biosciences Reports Third Quarter 2025 Results

Delivered Q3 2025 revenue of $83 million Q3 2025 non-dermatologic revenue increased by 67% over Q3 2024 Q3 2025 total test reports for our core revenue drivers (DecisionDx®-Melanoma, TissueCypher®) increased

Voir plus
Castle Biosciences Reports Third Quarter 2025 Results